Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
HumanPhenoPyloric stenosis

CYBB VAC14 RTL1 MMP23B LAMA3

3.91e-05104205HP:0002021
HumanPhenoAbnormality of the pylorus

CYBB VAC14 RTL1 MMP23B LAMA3

4.49e-05107205HP:0004400
DomainCyt_b245_heavy_chain

CYBB NOX1

8.51e-054712IPR000778
DomainNAD_binding_6

CYBB NOX1

2.96e-047712PF08030
DomainFAD_binding_8

CYBB NOX1

2.96e-047712PF08022
DomainFAD-bd_8

CYBB NOX1

2.96e-047712IPR013112
DomainFe_red_NAD-bd_6

CYBB NOX1

2.96e-047712IPR013121
DomainRetinoid-X_rcpt/HNF4

RXRB RXRG

6.29e-0410712IPR000003
Domainzf-C4

NR4A1 RXRB RXRG

7.11e-0446713PF00105
DomainZnf_hrmn_rcpt

NR4A1 RXRB RXRG

7.11e-0446713IPR001628
DomainNuclear_hrmn_rcpt

NR4A1 RXRB RXRG

7.11e-0446713IPR001723
DomainNUCLEAR_REC_DBD_2

NR4A1 RXRB RXRG

7.11e-0446713PS51030
DomainNUCLEAR_REC_DBD_1

NR4A1 RXRB RXRG

7.11e-0446713PS00031
DomainZnF_C4

NR4A1 RXRB RXRG

7.11e-0446713SM00399
Domain-

NR4A1 RXRB RXRG

7.57e-04477131.10.565.10
DomainHOLI

NR4A1 RXRB RXRG

8.05e-0448713SM00430
DomainNucl_hrmn_rcpt_lig-bd

NR4A1 RXRB RXRG

8.05e-0448713IPR000536
DomainHormone_recep

NR4A1 RXRB RXRG

8.05e-0448713PF00104
DomainFerric_reduct

CYBB NOX1

9.18e-0412712PF01794
DomainFe3_Rdtase_TM_dom

CYBB NOX1

9.18e-0412712IPR013130
Domain-

NR4A1 RXRB RXRG

1.33e-03577133.30.50.10
DomainZnf_NHR/GATA

NR4A1 RXRB RXRG

1.40e-0358713IPR013088
DomainPeptidase_aspartic_dom

RTL1 BACE2

1.87e-0317712IPR021109
DomainFd_Rdtase_FAD-bd

CYBB NOX1

2.34e-0319712IPR017927
DomainFAD_FR

CYBB NOX1

2.34e-0319712PS51384
DomainRiboflavin_synthase-like_b-brl

CYBB NOX1

2.34e-0319712IPR017938
DomainhEGF

JAG1 NOTCH4

5.05e-0328712PF12661
PathwayPID_RXR_VDR_PATHWAY

NR4A1 RXRB RXRG

1.30e-0426543M162
PathwayKEGG_MEDICUS_VARIANT_PAX8_PPARG_FUSION_TO_PPARG_MEDIATED_TRANSCRIPTION

RXRB RXRG

1.43e-045542M49023
PathwayWP_VITAMIN_A1_AND_A5X_PATHWAYS

RXRB RXRG

2.14e-046542M48097
PathwayWP_NEOVASCULARIZATION_PROCESSES

HIF1A JAG1 NOTCH4

3.76e-0437543M39506
PathwayWP_NUCLEAR_RECEPTORS

NR4A1 RXRB RXRG

4.08e-0438543M39657
PathwayWP_NUCLEAR_RECEPTORS

NR4A1 RXRB RXRG

4.08e-0438543MM15865
PathwayKEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY

RXRB RXRG

5.10e-049542M47629
PathwayWP_VITAMIN_A_AND_CAROTENOID_METABOLISM

RETSAT RXRB RXRG

5.88e-0443543M39554
PathwayWP_RETINOL_METABOLISM

RETSAT RXRB RXRG

6.30e-0444543MM15851
PathwayPID_A6B1_A6B4_INTEGRIN_PATHWAY

LAMA3 RXRB RXRG

7.18e-0446543M239
PathwayREACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS

JAG1 NOTCH4

7.75e-0411542M27882
PathwayREACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY

NR4A1 RXRB RXRG

8.14e-0448543MM14987
PathwayKEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380

JAG1 NOTCH4

9.27e-0412542M47532
PathwayREACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY

NR4A1 RXRB RXRG

1.09e-0353543M8276
PathwayKEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY

JAG1 NOTCH4

1.09e-0313542M47423
Pubmed

Formation of HERV-K and HERV-Fc1 Envelope Family Members is Suppressed on Transcriptional and Translational Level.

ERVFC1 ERVK-18

4.47e-06274233113941
Pubmed

Adverse cognitive effects of high-fat diet in a murine model of sleep apnea are mediated by NADPH oxidase activity.

CYBB NOX1

4.47e-06274223064009
Pubmed

NADPH oxidase and the degeneration of dopaminergic neurons in parkinsonian mice.

CYBB NOX1

4.47e-06274224379900
Pubmed

Jagged1 intracellular domain modulates steroidogenesis in testicular Leydig cells.

JAG1 NR4A1

4.47e-06274233378407
Pubmed

Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity.

JAG1 NOTCH4

4.47e-06274226387946
Pubmed

The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice.

CYBB NOX1

4.47e-06274216877542
Pubmed

Redox modifier genes in amyotrophic lateral sclerosis in mice.

CYBB NOX1

4.47e-06274217853944
Pubmed

Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis.

CYBB NOX1

4.47e-06274227212019
Pubmed

HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment.

CYBB HIF1A

4.47e-06274220876310
Pubmed

Ethanol induces oxidative stress in alveolar macrophages via upregulation of NADPH oxidases.

CYBB NOX1

4.47e-06274222412195
Pubmed

NOX2-ROS-HIF-1α signaling is critical for the inhibitory effect of oleanolic acid on rectal cancer cell proliferation.

CYBB HIF1A

4.47e-06274227938946
Pubmed

Differential Roles of the NADPH-Oxidase 1 and 2 in Platelet Activation and Thrombosis.

CYBB NOX1

4.47e-06274226988594
Pubmed

Insulation of the ubiquitous Rxrb promoter from the cartilage-specific adjacent gene, Col11a2.

COL11A2 RXRB

4.47e-06274218682388
Pubmed

VEO-IBD NOX1 variant highlights a structural region essential for NOX/DUOX catalytic activity.

CYBB NOX1

4.47e-06274237820403
Pubmed

The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus formation.

CYBB NOX1

4.47e-06274224494191
Pubmed

Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development.

RXRB RXRG

4.47e-0627429150186
Pubmed

The HIF1 target gene NOX2 promotes angiogenesis through urotensin-II.

CYBB HIF1A

4.47e-06274222399808
Pubmed

Differential expression of an acidic domain in the amino-terminal propeptide of mouse pro-alpha 2(XI) collagen by complex alternative splicing.

COL11A2 RXRB

4.47e-0627427836472
Pubmed

The mouse col11a2 gene. Some transcripts from the adjacent rxr-beta gene extend into the col11a2 gene.

COL11A2 RXRB

4.47e-0627428981332
Pubmed

Netrin-1 abrogates ischemia/reperfusion-induced cardiac mitochondrial dysfunction via nitric oxide-dependent attenuation of NOX4 activation and recoupling of NOS.

CYBB NOX1

4.47e-06274225066694
Pubmed

JAG1-NOTCH4 mechanosensing drives atherosclerosis.

JAG1 NOTCH4

4.47e-06274236044575
Pubmed

Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia.

CYBB HIF1A

4.47e-06274221302291
Pubmed

Nur77 variants solely comprising the amino-terminal domain activate hypoxia-inducible factor-1α and affect bone marrow homeostasis in mice and humans.

HIF1A NR4A1

4.47e-06274230111591
Pubmed

Activation of NADPH oxidases leads to DNA damage in esophageal cells.

CYBB NOX1

4.47e-06274228855537
Pubmed

NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in mice.

CYBB NOX1

4.47e-06274219661248
Pubmed

Anaerobic Respiration of NOX1-Derived Hydrogen Peroxide Licenses Bacterial Growth at the Colonic Surface.

CYBB NOX1

4.47e-06274233301718
Pubmed

Endothelial NADPH oxidases: which NOX to target in vascular disease?

CYBB NOX1

4.47e-06274225066192
Pubmed

Hypoxia Inducible Factor-1α Potentiates Jagged 1-Mediated Angiogenesis by Mesenchymal Stem Cell-Derived Exosomes.

HIF1A JAG1

4.47e-06274228376567
Pubmed

In the absence of reactive oxygen species, T cells default to a Th1 phenotype and mediate protection against pulmonary Cryptococcus neoformans infection.

CYBB NOX1

4.47e-06274217015737
Pubmed

The NADPH oxidase Nox2 regulates VEGFR1/CSF-1R-mediated microglial chemotaxis and promotes early postnatal infiltration of phagocytes in the subventricular zone of the mouse cerebral cortex.

CYBB NOX1

4.47e-06274223836548
Pubmed

NADPH Oxidases Are Essential for Macrophage Differentiation.

CYBB NOX1

4.47e-06274227489105
Pubmed

Retinoid x receptor gamma control of affective behaviors involves dopaminergic signaling in mice.

RXRB RXRG

4.47e-06274220620876
Pubmed

Separable cis-regulatory elements that contribute to tissue- and site-specific alpha 2(XI) collagen gene expression in the embryonic mouse cartilage.

COL11A2 RXRB

4.47e-0627428830784
Pubmed

Nox2 and Cyclosporine-Induced Renal Hypoxia.

CYBB HIF1A

4.47e-06274226950727
Pubmed

NADPH oxidase NOX2 defines a new antagonistic role for reactive oxygen species and cAMP/PKA in the regulation of insulin secretion.

CYBB NOX1

1.34e-05374222933115
Pubmed

Development of an improved and specific inhibitor of NADPH oxidase 2 to treat traumatic brain injury.

CYBB NOX1

1.34e-05374236709665
Pubmed

Role of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brain.

CYBB NOX1

1.34e-05374222628375
Pubmed

Amyloid β-induced astrogliosis is mediated by β1-integrin via NADPH oxidase 2 in Alzheimer's disease.

CYBB NOX1

1.34e-05374227709751
Pubmed

The NADPH Oxidase Nox2 Mediates Vitamin D-Induced Vascular Regeneration in Male Mice.

CYBB NOX1

1.34e-05374227399878
Pubmed

NADPH oxidase-dependent generation of lysophosphatidylserine enhances clearance of activated and dying neutrophils via G2A.

CYBB NOX1

1.34e-05374218824544
Pubmed

Perturbation of ubiquitin homeostasis promotes macrophage oxidative defenses.

CYBB NOX1

1.34e-05374231308397
Pubmed

Genetic deletion of Nox4 enhances cancerogen-induced formation of solid tumors.

CYBB NOX1

1.34e-05374233836590
Pubmed

NADPH Oxidase and Guanylate Binding Protein 5 Restrict Survival of Avirulent Type III Strains of Toxoplasma gondii in Naive Macrophages.

CYBB NOX1

1.34e-05374230154263
Pubmed

Crystal structure of the ligand-binding domain of the ultraspiracle protein USP, the ortholog of retinoid X receptors in insects.

RXRB RXRG

1.34e-05374211053444
Pubmed

Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration.

CYBB NOX1

1.34e-05374220877715
Pubmed

Impaired locomotion and dopamine signaling in retinoid receptor mutant mice.

RXRB RXRG

1.34e-0537429452386
Pubmed

Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation.

JAG1 NOTCH4

1.34e-05374214988227
Pubmed

Retinoid X receptors: X-ploring their (patho)physiological functions.

RXRB RXRG

1.34e-05374215608692
Pubmed

DLL4 and Jagged1 are angiogenic targets of orphan nuclear receptor TR3/Nur77.

JAG1 NR4A1

1.34e-05374230930165
Pubmed

Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase.

CYBB NOX1

1.34e-05374222456182
Pubmed

Retinoid receptors trigger neuritogenesis in retinal degenerations.

RXRB RXRG

1.34e-05374221940995
Pubmed

A constitutive NADPH oxidase-like system containing gp91phox homologs in human keratinocytes.

CYBB NOX1

1.34e-05374215102091
Pubmed

NADPH oxidase restrains the matrix metalloproteinase activity of macrophages.

CYBB NOX1

1.34e-05374215983040
Pubmed

Selective ligand activity at Nur/retinoid X receptor complexes revealed by dimer-specific bioluminescence resonance energy transfer-based sensors.

NR4A1 RXRG

1.34e-05374226148973
Pubmed

An essential role for retinoid receptors RARbeta and RXRgamma in long-term potentiation and depression.

RXRB RXRG

1.34e-0537429883728
Pubmed

RXR gamma null mice are apparently normal and compound RXR alpha +/-/RXR beta -/-/RXR gamma -/- mutant mice are viable.

RXRB RXRG

1.34e-0537428799145
Pubmed

Inhibition of xanthine oxidoreductase protects against contrast-induced renal tubular injury by activating adenosine monophosphate-activated protein kinase.

HIF1A NOX1

1.34e-05374231560952
Pubmed

Intrarenal artery superoxide is mainly NADPH oxidase-derived and modulates endothelium-dependent dilation in elderly patients.

CYBB NOX1

1.34e-05374219843513
Pubmed

Cooperative formation of high-order oligomers by retinoid X receptors: an unexpected mode of DNA recognition.

RXRB RXRG

1.34e-0537427831303
Pubmed

Receptor activator of nuclear factor-kappaB ligand-induced mouse osteoclast differentiation is associated with switching between NADPH oxidase homologues.

CYBB NOX1

1.34e-05374219409483
Pubmed

Gp91phox NADPH oxidase modulates litter size by regulating mucin1 in the uterus of mice.

CYBB NOX1

1.34e-05374228301257
Pubmed

Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair.

CYBB NOX1

1.34e-05374223241962
Pubmed

Physical mapping of the Ring1, Ring2, Ke6, Ke4, Rxrb, Col11a2, and RT1.Hb genes in the rat major histocompatibility complex.

COL11A2 RXRB

1.34e-0537428662089
Pubmed

Endosomal NADPH oxidase regulates c-Src activation following hypoxia/reoxygenation injury.

CYBB NOX1

1.34e-05374218397177
Pubmed

Characterization of Notch Signalling Pathway Members in Normal Prostate, Prostatic Intraepithelial Neoplasia (PIN) and Prostatic Adenocarcinoma.

JAG1 NOTCH4

1.34e-05374226341090
Pubmed

Nur77 activated by hypoxia-inducible factor-1alpha overproduces proopiomelanocortin in von Hippel-Lindau-mutated renal cell carcinoma.

HIF1A NR4A1

1.34e-05374214729605
Pubmed

Characterization of three RXR genes that mediate the action of 9-cis retinoic acid.

RXRB RXRG

1.34e-0537421312497
Pubmed

Detection of retinoid X receptors using specific monoclonal and polyclonal antibodies.

RXRB RXRG

1.34e-0537427980510
Pubmed

The SLC34A2-ROS-HIF-1-induced up-regulation of EZH2 expression promotes proliferation and chemo-resistance to apoptosis in colorectal cancer.

HIF1A SLC34A2

1.34e-05374230038060
Pubmed

Immunohistochemical detection of the retinoid X receptors alpha, beta, and gamma in human prostate.

RXRB RXRG

1.34e-05374212514092
Pubmed

Chromosomal localization of the human retinoid X receptors.

RXRB RXRG

1.34e-0537428034312
Pubmed

Unique patterns of Notch1, Notch4 and Jagged1 expression in ovarian vessels during folliculogenesis and corpus luteum formation.

JAG1 NOTCH4

1.34e-05374215939383
Pubmed

NADPH Oxidases Are Required for Full Platelet Activation In Vitro and Thrombosis In Vivo but Dispensable for Plasma Coagulation and Hemostasis.

CYBB NOX1

1.34e-05374233267663
Pubmed

The role of retinoid X receptor messenger RNA expression in curatively resected non-small cell lung cancer.

RXRB RXRG

1.34e-05374211839661
Pubmed

NADPH oxidase subunit, gp91(phox) homologue, preferentially expressed in human colon epithelial cells.

CYBB NOX1

1.34e-05374210974555
Pubmed

NOX1 to NOX2 switch deactivates AMPK and induces invasive phenotype in colon cancer cells through overexpression of MMP-7.

CYBB NOX1

1.34e-05374226116564
Pubmed

NADPH oxidase deficiency results in reduced alveolar macrophage 5-lipoxygenase expression and decreased leukotriene synthesis.

CYBB NOX1

1.34e-05374217761955
Pubmed

Differential expression of NADPH oxidases in megakaryocytes and their role in polyploidy.

CYBB NOX1

1.34e-05374219471020
Pubmed

Chromosomal localization of the proteasome Z subunit gene reveals an ancient chromosomal duplication involving the major histocompatibility complex.

COL11A2 RXRB NOTCH4

1.59e-05237438799160
Pubmed

Alveolar macrophages from septic mice promote polymorphonuclear leukocyte transendothelial migration via an endothelial cell Src kinase/NADPH oxidase pathway.

CYBB NOX1

2.67e-05474219050294
Pubmed

Retinoic acid biosynthetic activity and retinoid receptors in the olfactory mucosa of adult mice.

RXRB RXRG

2.67e-05474210079186
Pubmed

Novel function of orphan nuclear receptor Nur77 in stabilizing hypoxia-inducible factor-1alpha.

HIF1A NR4A1

2.67e-05474215385570
Pubmed

Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin.

JAG1 NOTCH4

2.67e-05474217984306
Pubmed

Loss of retinoid X receptor gamma subunit impairs group 1 mGluR mediated electrophysiological responses and group 1 mGluR dependent behaviors.

RXRB RXRG

2.67e-05474233692389
Pubmed

Notch1 and Notch4 core binding domain peptibodies exhibit distinct ligand-binding and anti-angiogenic properties.

JAG1 NOTCH4

2.67e-05474236376768
Pubmed

Lactate released by inflammatory bone marrow neutrophils induces their mobilization via endothelial GPR81 signaling.

CYBB HIF1A

2.67e-05474232669546
Pubmed

HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells.

HIF1A NOX1

2.67e-05474220347035
Pubmed

Cyba-deficient mice display an increase in hematopoietic stem cells and an overproduction of immunoglobulins.

CYBB NOX1

2.67e-05474231919083
Pubmed

Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently.

RXRB RXRG

2.67e-0547421310259
Pubmed

Human eye colour and HERC2, OCA2 and MATP.

SLC34A2 OCA2

2.67e-05474220457063
Pubmed

Pregnane X Receptor Expression in Human Pancreatic Adenocarcinoma: Associations With Clinicopathologic Parameters, Tumor Proliferative Capacity, Patients' Survival, and Retinoid X Receptor Expression.

RXRB RXRG

2.67e-05474226355550
Pubmed

Retinoids activate RXR/CAR-mediated pathway and induce CYP3A.

RXRB RXRG

2.67e-05474219686701
Pubmed

Constitutive NADPH oxidase 4 activity resides in the composition of the B-loop and the penultimate C terminus.

CYBB NOX1

2.67e-05474222277655
Pubmed

Absence of thyroid hormone receptor beta-retinoid X receptor interactions in auditory function and in the pituitary-thyroid axis.

RXRB RXRG

2.67e-0547429804293
Pubmed

NADPH oxidase Nox2 is required for hypoxia-induced mobilization of endothelial progenitor cells.

CYBB NOX1

2.67e-05474219679834
Pubmed

A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1.

NR4A1 RXRB

4.45e-0557427705655
Pubmed

Developmental expression of murine retinoid X receptor (RXR) genes.

RXRB RXRG

4.45e-0557428199055
Pubmed

Nur77 upregulates HIF-alpha by inhibiting pVHL-mediated degradation.

HIF1A NR4A1

4.45e-05574218305400
Pubmed

Retinoic acid signaling is necessary for the development of the organ of Corti.

RXRB RXRG

4.45e-05574210452855
Pubmed

Characterization of Brx, a novel Dbl family member that modulates estrogen receptor action.

AKAP13 RXRB

4.45e-0557429627117
Cytoband15q24-q25

AKAP13 TMED3

1.53e-05474215q24-q25
Cytoband5q23.2

CTXN3 PPIC

1.23e-03327425q23.2
CytobandEnsembl 112 genes in cytogenetic band chr6p21

HCG22 COL11A2 MDGA1 RXRB NOTCH4

1.34e-03503745chr6p21
Cytoband16q24.3

SLC22A31 FANCA

3.23e-035274216q24.3
GeneFamilyNuclear hormone receptors

NR4A1 RXRB RXRG

2.45e-044945371
CoexpressionGSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP

SLC13A4 RTCA ADGRB2 LAMA3 LSAMP TMEM223 NR4A1

1.31e-06200727M7535
CoexpressionGSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_UP

ATG9B ARHGEF28 MRGPRX1 LAMA3 MDGA1 RXRG

1.68e-05196726M6156
CoexpressionDESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS

COL8A2 IL17RE ADGRB2 LAMA3 SLC34A2 LSAMP MDGA1

2.45e-05313727M40228
CoexpressionGSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_DN

ATG9B HIF1A TMEM35A BACE2 RXRG

4.10e-05139725M8919
CoexpressionHOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN

MDN1 EMB FXYD5 PPIC

5.49e-0575724M7405
ToppCellControl-Myeloid-MoAM3,_VCAN|Myeloid / Condition, Lineage and Cell class

EMB ASGR1 FRMPD2 FXYD5 LAMA3 BCAT1

5.74e-071867260bf16ac48931b62bb3c33d63ff4279654148e293
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

IL17RE LAMA3 SLC34A2 BCAT1 SLC22A31 TMED3

8.26e-0719872650852713c017217c79777c95857097103bcf2fbe
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

IL17RE LAMA3 SLC34A2 BCAT1 SLC22A31 TMED3

8.26e-07198726f006d68e6c51923be7772eea118546a5762e8a5e
ToppCellControl_saline-Epithelial_alveolar|Control_saline / Treatment groups by lineage, cell group, cell type

IL17RE TMEM191C LAMA3 SLC34A2 BCAT1 SLC22A31

8.26e-07198726532b7ef4ad46fe35ad2c6bdf89f70a17f1a2e2e2
ToppCellLPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMA3 SLC34A2 BCAT1 AKAP13 SLC22A31

1.99e-061277255b0adbcafad31a6759c9bdce2f7f9591a8edc450
ToppCellE18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_mature_2|E18.5-samps / Age Group, Lineage, Cell class and subclass

COL8A2 ADGRB2 LSAMP SCRIB LTK

2.32e-06131725f2eee150f5cff852e8f52f09b35e26f17d80833b
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

2.50e-061337255bf5e654653e2c340891f51e3f2a30441b7b6b2b
ToppCellControl-Epithelial_alveolar-AT_1-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TMEM191C LAMA3 SLC34A2 BCAT1 SLC22A31

3.44e-0614272594e277f038f4006d99ff50222b0f5cf89bc3d46d
ToppCellfacs-Large_Intestine-Distal-18m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYBB COL8A2 TMC7 EMB FXYD5

5.98e-06159725709b57f992a29878cc899d760d144d36cb5cb280
ToppCellLPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MMP23B LAMA3 BCAT1 LSAMP AKAP13

1.01e-05177725b7fee75de7e96924af488a5baa2334711889ae7c
ToppCellLPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

1.06e-05179725fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCellfacs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL8A2 SLC13A4 EMB IL17RE OCA2

1.09e-05180725729f0d7af573c7796d8e28e6eec3af2fc0bd33a2
ToppCellfacs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL8A2 SLC13A4 EMB IL17RE OCA2

1.09e-051807259ef79a7c60227e352ac166c7274adb31f585f5ca
ToppCellLPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

1.12e-051817250513b9e6673ff7bf8e72ba123ca3794b65d10170
ToppCellMesenchymal_cells-Stromal_fibro.|Mesenchymal_cells / Lineage and Cell class

TMC7 LSAMP CTXN3 NR4A1 BACE2

1.12e-05181725f8d914fdc06aaa75a4dc9158daf574ca28fa5432
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMA3 SLC34A2 BCAT1 SLC22A31 TMED3

1.15e-05182725cc79e0cc21e2fdc4ef77f052818d27b9f707aec1
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_2-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 SLC34A2 BCAT1 SLC22A31 TMED3

1.15e-051827251e2149b222a3e9f64841aed45288a6f29394e7b0
ToppCellLPS_only-Epithelial_alveolar-AT_2-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 SLC34A2 BCAT1 SLC22A31 TMED3

1.15e-05182725d1a1feef318062f25493355d7beee8e5fb0e4206
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

1.15e-0518272517ed11a7ea366dd3106400511d5e628d3f1a9c3e
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMA3 SLC34A2 BCAT1 SLC22A31 TMED3

1.18e-0518372506ac66726ec53db810ebb90ec69cfdb903da53f6
ToppCellLPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

1.18e-05183725e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCellFrontal_cortex-Endothelial-ENDOTHELIAL_TIP|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

COL8A2 SLC13A4 IL17RE ASGR1 CTXN3

1.21e-05184725235890e8b424f4386b6ea52d173d20a00898df73
ToppCellControl-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

1.21e-0518472551e129b3fcc2df083eda05a3afe3717218b1e52b
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

1.21e-05184725ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCellControl-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

1.25e-051857250d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCellControl-Epithelial_alveolar-AT_2-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

1.25e-051857258ca1374501eca01d8468130b74d50abfd4329fbe
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

1.25e-05185725fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

1.25e-05185725929b68b05b7686341329ac756d7df172cb4b810b
ToppCellLPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

1.28e-05186725e0a2ea4b46af742bc7c9b2072bb85e27d5c92712
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

1.28e-051867254e94158db52df41d71e67b02b9895a358eebee0f
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

1.28e-05186725e83718fabb057100835d3357df407f283d23fe16
ToppCellLPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

1.31e-05187725201ff693e4756ee3e44762885b3a303a77eb535b
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

1.31e-0518772558d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCellLPS-IL1RA-Epithelial_alveolar|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

1.35e-051887256164d467b612767ceba15de34176bcc8e8c36ab8
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

1.35e-0518872543a0508d2524a5b310e89e9422843dcaab999bc3
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

1.35e-051887254bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCellPND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

JAG1 FXYD5 BACE2 GRP NOTCH4

1.38e-051897251e1afa66b32ae752c0a42b02b80f10205464569c
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.

COL11A2 FXYD5 NR4A1 BACE2 RXRG

1.53e-05193725e1de67ddada87229f5db0ec193a6da8745a86a64
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.

COL11A2 FXYD5 NR4A1 BACE2 RXRG

1.53e-05193725b6f5a85210e60798205eaf5884cdb540f549d08a
ToppCellControl_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type

ARHGEF28 IL17RE LAMA3 SLC34A2 SLC22A31

1.69e-0519772544a59dfb889577b3160a5b13ada1276771a00241
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

1.69e-051977251485933986921ff45669d9b7501c8d17050b3e97
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

IL17RE LAMA3 SLC34A2 BCAT1 SLC22A31

1.69e-051977253d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCellLPS_only-Epithelial_alveolar-AT_2|LPS_only / Treatment groups by lineage, cell group, cell type

ARHGEF28 SLC34A2 BCAT1 SLC22A31 TMED3

1.73e-05198725d087e738d69ca9853553fde46d4e7a8906439d32
ToppCellControl_saline-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|Control_saline / Treatment groups by lineage, cell group, cell type

IL17RE LAMA3 SLC34A2 BCAT1 SLC22A31

1.73e-05198725030ef63e2fc5b3d601c1a48462d797aa19ee7ff5
ToppCellControl_saline-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|Control_saline / Treatment groups by lineage, cell group, cell type

IL17RE LAMA3 SLC34A2 SLC22A31 TMED3

1.73e-05198725827aa9d919bf6d670961e5501e17d351676127e3
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ARHGEF28 LAMA3 SLC34A2 BCAT1 SLC22A31

1.73e-05198725285f729140b1df029c24f6ca1d2438470ac51794
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

TMEM191C LAMA3 SLC34A2 BCAT1 SLC22A31

1.73e-05198725b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

LAMA3 SLC34A2 BCAT1 SLC22A31 TMED3

1.73e-051987258d9858dcb21f20d0c040b22a2cae543eaebd54bc
ToppCellLPS_anti-TNF-Epithelial_alveolar|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

LAMA3 SLC34A2 BCAT1 SLC22A31 TMED3

1.73e-0519872553e9ed1b19cb26be58da0f37057caca0cdfaabeb
ToppCelldroplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL11A2 MMP23B BCAT1 PPIC TMED3

1.73e-05198725b086af292a508a156266c2d899ba1caf820bf61c
ToppCelldroplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL11A2 MMP23B BCAT1 PPIC TMED3

1.73e-051987251b90d632e59c3c47b936e829cceeb0334f05f34f
ToppCellControl_saline-Epithelial_alveolar-AT_1-2_Progenitor|Control_saline / Treatment groups by lineage, cell group, cell type

IL17RE LAMA3 SLC34A2 BCAT1 SLC22A31

1.73e-05198725cd8a26de6c1cb9c42635146bb7220dd1b41ee97d
ToppCelldroplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL8A2 COL11A2 MMP23B PPIC TMED3

1.73e-05198725524305c5d7b1d53e86ec0af775efefa3e0955e47
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

LAMA3 SLC34A2 BCAT1 SLC22A31 TMED3

1.77e-05199725180b3997174fd63bdf3b828063a13483eb4cab29
ToppCellLPS_IL1RA-Epithelial_alveolar|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

LAMA3 SLC34A2 BCAT1 SLC22A31 TMED3

1.77e-051997255b140ac88ebc25ce397ae577e48f3e271faf46e7
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

IL17RE LAMA3 SLC34A2 BCAT1 SLC22A31

1.77e-051997251c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_1-AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

TMEM191C LAMA3 SLC34A2 SLC22A31 TMED3

1.77e-051997258c9ec5f05b79cf5ae1bf7aade603c171fb0226a9
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

LAMA3 SLC34A2 BCAT1 SLC22A31 TMED3

1.77e-05199725bb2e839197b9a44b632c1bb716e48d885a1c8713
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

TMEM191C LAMA3 SLC34A2 BCAT1 SLC22A31

1.77e-05199725a270630626df614f8605abddb7dee7c4d74f6149
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

LAMA3 SLC34A2 BCAT1 SLC22A31 TMED3

1.77e-05199725329c381404d4972871142dd7f7ee78fbcc365aa1
ToppCellLPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type

IL17RE LAMA3 SLC34A2 BCAT1 SLC22A31

1.81e-052007252dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

IL17RE LAMA3 SLC34A2 BCAT1 SLC22A31

1.81e-05200725ddfb1f006365bf16203ee49f20200f68220cc288
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

IL17RE LAMA3 SLC34A2 BCAT1 SLC22A31

1.81e-052007258683445ad5b70748c4a1f12eb77d47623085147e
ToppCellFrontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

SLC13A4 ASGR1 MMP23B SLC34A2

1.87e-05977242cd5cafdf0a9a468baaafd4613d790fc048ee53e
ToppCellFrontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Coch_(Coch)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

SLC13A4 ASGR1 MMP23B SLC34A2

1.87e-0597724adda7a49b7754ed110e212346768bf52107c26fc
ToppCellFrontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Coch_(Coch)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

SLC13A4 ASGR1 MMP23B SLC34A2

1.87e-05977246d865ec3a413f595de17e0a5f8c61666ebb3e252
ToppCellLPS-IL1RA-Epithelial_alveolar-Mes-Like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 TMEM191C LAMA3 BCAT1

2.36e-05103724c11bb0238e81a42dad5d7687c9d22474129d803d
ToppCellLPS-IL1RA-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 TMEM191C SLC34A2 BCAT1

2.55e-051057249ed5482b445eacf16d5769f79438098b0e71123a
ToppCellFrontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Endothelial_Tip.Dcn.Dapl1_(Dapl1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

COL8A2 IL17RE ASGR1 CTXN3

2.65e-051067247079111add27d7b3411dfe739280d62dc256a174
ToppCellFrontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Endothelial_Tip.Dcn.Dapl1_(Dapl1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

COL8A2 IL17RE ASGR1 CTXN3

2.65e-05106724a6334b67be05f78145b57271b7959471b80bd67f
ToppCellEntopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32

COL8A2 SLC13A4 ASGR1 MMP23B

5.21e-05126724f1f24b06d301c266226d1a59dd28585f5ac68f29
ToppCellEntopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32

COL8A2 SLC13A4 ASGR1 MMP23B

5.21e-05126724fe6900eb37e4f09465a1276586c73dd38545fa2a
ToppCellEntopeduncular-Endothelial-ENDOTHELIAL_TIP|Entopeduncular / BrainAtlas - Mouse McCarroll V32

COL8A2 SLC13A4 ASGR1 MMP23B

5.21e-051267243d507f829882d043f633db2612b76936e2042445
ToppCellEntopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32

COL8A2 SLC13A4 ASGR1 MMP23B

5.21e-051267241ac4cc747e466bc79e33b97608b19ad29a7a6a41
ToppCellEntopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)|Entopeduncular / BrainAtlas - Mouse McCarroll V32

COL8A2 SLC13A4 ASGR1 MMP23B

5.21e-051267242de551d7a8765afec1da8852727c79fec90f45f8
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARHGEF28 LAMA3 SLC34A2 BCAT1

5.88e-051307246434d9106ccb38786dad36fab80163dfc07b6eb7
ToppCellGlobus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

COL8A2 SLC13A4 ASGR1 MMP23B

6.24e-05132724560e836764ed7806fb18282dfebe434d30112a9a
ToppCellFrontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

COL8A2 IL17RE ASGR1 CTXN3

6.81e-051357244451c44f3ad788437f4e2ae81049fbbab53f967e
ToppCellFrontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

COL8A2 IL17RE ASGR1 CTXN3

6.81e-0513572445f67f33c8320d9fb6dbceae603b564f6a8ffd1e
ToppCellSubstantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Alcam_(Alcam)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

SLC13A4 IL17RE ASGR1 MMP23B

8.28e-051427246a656d28c9f5dfb03a3a2d908cf2edbe0a5b1206
ToppCellSubstantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

SLC13A4 IL17RE ASGR1 MMP23B

8.28e-05142724671ba8869db7a6dc69fd1caf0e561f15a312b170
ToppCellSubstantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

SLC13A4 IL17RE ASGR1 MMP23B

8.28e-051427243557084150670fd2e2634fc674f228ab85181b59
ToppCellSubstantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Alcam_(Alcam)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

SLC13A4 IL17RE ASGR1 MMP23B

8.28e-05142724a3d1f4b570b75402171e38c5a7c88e2896520c8f
ToppCelllung-Type_II_Pneumocytes|lung / shred on tissue and cell subclass

SLC34A2 BCAT1 AKAP13 SLC22A31

9.47e-051477248a3039de45b8087f8319e2e37329acf7278219b7
ToppCellfacs-Brain_Myeloid-Cerebellum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYBB EMB JAG1 FXYD5

1.05e-041517243105b8c0c401faa92e1ab8223d435b21ed45c5b7
ToppCellMyeloid-C_(Monocyte)|World / shred on cell class and cell subclass (v4)

CYBB EMB FXYD5 NR4A1

1.08e-041527249145dc014ed7f154c158d454dc2b9754396afcca
ToppCellLPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMA3 SLC34A2 BCAT1 SLC22A31

1.11e-04153724e7a074ea8232bacf924be78a244a8507c7e1ebc8
ToppCellfacs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYBB EMB JAG1 FXYD5

1.11e-041537240ef7c45cdd854c79e527006034029767f8e108b2
ToppCellPosterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

COL8A2 SLC13A4 IL17RE ASGR1

1.11e-04153724151c469b26f9adf04dd6f117f03bef760cc3d45d
ToppCellfacs-Brain_Myeloid-Cortex-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYBB EMB FXYD5 NR4A1

1.13e-041547241e088b0d4a44267f46a9b643f46a1aba784686b1
ToppCellfacs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYBB EMB JAG1 FXYD5

1.19e-041567242ba838bc864c2c1767bcab7bb4d790af96b91387
ToppCellTCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9

DMGDH KLHL41 NR4A1 RXRG

1.31e-041607248a41e2c96e0e170ac35daf6c403bf961b8d7c30b
ToppCellRV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

JAG1 LAMA3 OCA2 SLC22A31

1.31e-0416072429c9b4770d0e73d59cffc7937b179484c76b6dcc
ToppCellTCGA-Bladder-Solid_Tissue_Normal|TCGA-Bladder / Sample_Type by Project: Shred V9

DMGDH KLHL41 NR4A1 RXRG

1.31e-04160724d6678996e12eaf2b735f1dfae32418cb2fabf268
ToppCellPBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CYBB HIF1A EMB SLC22A31

1.31e-04160724bb1bb3673059768c0ea0160d29fff127f3a4ecb4
ToppCellTCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9

DMGDH KLHL41 NR4A1 RXRG

1.31e-04160724c8dc575562b463fd30832d322c28006f18f7ab9c
ToppCellPBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CYBB HIF1A EMB SLC22A31

1.31e-0416072476f49b8b4450fa8acd36326bfa36a5d1f4bd95fb
ToppCellfacs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYBB EMB FXYD5 NR4A1

1.31e-041607241f7acdc8b08152d5817fc53bbf47b4a22d9c91b5
ToppCellRV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper

JAG1 LAMA3 OCA2 SLC22A31

1.34e-0416172447b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ARHGEF28 EMB CTXN3 GRP

1.38e-0416272458da6bc04cdac0002b0e6a751c96ff95e1a7f70f
Drug13,14-dihydroretinol

RETSAT RXRB RXRG

2.89e-075713CID000446798
Drugdiazepinylbenzoic acid

NR4A1 RXRB RXRG

3.43e-0610713ctd:C438269
Diseaseskin melanoma (is_implicated_in)

OCA2 FANCA

4.54e-0414672DOID:8923 (is_implicated_in)
Diseaseendoplasmic reticulum resident protein 29 measurement

HCG22 NOTCH4

5.97e-0416672EFO_0020346
Diseasepulmonary hypertension (biomarker_via_orthology)

CYBB HIF1A NOX1

8.11e-0480673DOID:6432 (biomarker_via_orthology)
Diseaseskin sensitivity to sun

OCA2 FANCA

8.47e-0419672EFO_0004795
Diseaseage-related hearing impairment

COL11A2 ARHGEF28 ADGRB2 FXYD5 MDGA1

8.57e-04324675EFO_0005782
DiseaseCarcinoma, Pancreatic Ductal

JAG1 NOTCH4

1.36e-0324672C0887833
Diseasesunburn

ADAM30 OCA2 FANCA

1.37e-0396673EFO_0003958
DiseaseC-X-C motif chemokine 10 measurement

ARHGEF28 RTCA HECTD4

1.98e-03109673EFO_0008056
DiseaseMyocardial Failure

CYBB HIF1A NOX1

2.03e-03110673C1959583
DiseaseCongestive heart failure

CYBB HIF1A NOX1

2.03e-03110673C0018802
DiseaseHeart failure

CYBB HIF1A NOX1

2.03e-03110673C0018801
DiseaseLeft-Sided Heart Failure

CYBB HIF1A NOX1

2.03e-03110673C0023212
DiseaseHeart Failure, Right-Sided

CYBB HIF1A NOX1

2.03e-03110673C0235527
DiseaseHeart Decompensation

CYBB HIF1A NOX1

2.03e-03110673C1961112
Diseasepancreas volume

FRMPD2 GRP

2.12e-0330672EFO_0600045

Protein segments in the cluster

PeptideGeneStartEntry
ACPLLLSVILSLRLA

ADGRB2

16

O60241
LLQRLCSGPRLLLLS

ASGR1

31

P07306
LIVLLLLPFRCQRRP

BACE2

486

Q9Y5Z0
LDGIILPGVTRRCIL

BCAT1

281

P54687
LGILIVRCFRILLDP

CTXN3

41

Q4LDR2
SSVVRRLGIPECILL

AKAP13

2131

Q12802
RLGIPECILLVTQRI

AKAP13

2136

Q12802
RLCLLTIVGLILPTR

FXYD5

6

Q96DB9
ICLVLLVCFPLLRLL

OCA2

516

Q04671
CLSRLLGKLPELRTL

NR4A1

551

P22736
LARRRGIPECILLVT

ARHGEF28

986

Q8N1W1
PEFLLLRTLARCLIL

ANAPC1

1401

Q9H1A4
VLLRCSLLRGSPQRI

MDGA1

556

Q8NFP4
LILLPVCRNLLSFLR

NOX1

66

Q9Y5S8
LRLLLCLLLLSSRPG

PTPRN

16

Q16849
DCTVLVGRQLRPLLL

MDN1

56

Q9NU22
LLLLVLRVLPACGAT

LAMA3

21

Q16787
SKILRLLCTVARLLP

NCBP1

66

Q09161
LLITAKLLVLPLLCR

GPR155

281

Q7Z3F1
IILIPSDLACRLLGQ

HIF1A

771

Q16665
LTLLGVVLALTCRRP

IL17RE

466

Q8NFR9
CVGLSLRATPRLILL

LTK

576

P29376
LFILPGNILIICTIR

OR4M1

36

Q8NGD0
QLIRCLRSPLETLAL

PRAMEF18

286

Q5VWM3
LPLVLLALVLCLAPR

GRP

6

P07492
RCHRLLLLLPLVLGL

COL11A2

6

P13942
LVGLARPLVLALLLV

KCT2

26

Q8NC54
LAILRLGLLLDCPRL

KLHL41

136

O60662
RVACLLNVPIESLRL

HECTD4

3501

Q9Y4D8
QLVTPCRLRICIILI

GPR52

151

Q9Y2T5
LPLQVRLCPDRISLI

NBAS

1231

A2RRP1
PLLLLLLLLRCSERG

HCG22

6

E2RYF7
TLIGPTRLRIIKLCG

ERVK-18

381

Q9QC07
ILGCRVRIPAEVLIL

GMPPA

386

Q96IJ6
IFLSQCRLLLLLVPT

ADAM30

6

Q9UKF2
VPGIVRLRTLLCKVL

CLCN6

171

P51797
LAACVLTLPRSLLLE

KLHL22

586

Q53GT1
PLGISVLRCIRLLRI

CACNA1S

521

Q13698
LLRGAPQEVTLLLCR

FRMPD2

1151

Q68DX3
RVLPAVLTRLCQLLR

FANCA

756

O15360
LLLLLLVLVLGCGPR

COL8A2

11

P25067
CAERIRSSPLLVLLL

ATG9B

271

Q674R7
AQLLRGLLLRSCPLQ

DMGDH

6

Q9UI17
LILLPVCRNLLSFLR

CYBB

66

P04839
RARTPRLLLLQCLLA

EMB

11

Q6PCB8
RNLCLPISLVPRLTL

ERVFC1

351

P60507
VLALLCVLLLPESRS

SLC22A31

496

A6NKX4
GLLRVRKLLLVVCVP

SLC13A4

6

Q9UKG4
GRCLALLELLTVLPE

IPO13

161

O94829
GITPLVRRLLLCEEL

KCTD3

101

Q9Y597
RRVPCTLLLGLAVVL

FAM171B

6

Q6P995
GRPLSLLLALLCALR

JAG1

11

P78504
LPVVQLLDRCGLLTR

RETSAT

216

Q6NUM9
LVLLRVRQCLSLRPA

RTL1

1096

A6NKG5
EVRGPFIIRQLCLLL

VAC14

546

Q08AM6
RLLLPLVLCVGLGAL

PPIC

6

P45877
RCVLGALQVLLTLPL

TMEM191C

281

A6NGB0
LLRLLCLLPTGLPVR

LSAMP

16

Q13449
VALCLLPALVLLARL

MMP23B

26

O75900
LLRVPLRVLVLTGLQ

RGP1

151

Q92546
SALLRPCLELSLLVR

SCRIB

1076

Q14160
LVLLIRILCGSRKIP

MRGPRX1

196

Q96LB2
LLLLLLCVSVVRPRG

NOTCH4

11

Q99466
LRLPALRSIGLKCLE

RXRB

491

P28702
IILVLCLRLLQSRCP

SLC34A2

566

O95436
LLRPLRGLLSLRSCL

PIGV

101

Q9NUD9
GLLAVLRPLLTCRPL

TMEM223

11

A0PJW6
LSCLLGLPLRVQKIR

RTCA

26

O00442
VLLLLLLLRRAEQPC

TMED3

11

Q9Y3Q3
LRLPALRSIGLKCLE

RXRG

421

P48443
SLLLGPARLCLRLLL

ZDHHC16

6

Q969W1
VIPLAVRGRALSLLL

TBC1D28

101

Q2M2D7
PGNCVLVLREVLTLL

SFMBT1

531

Q9UHJ3
LPLRGLRALCRVLLF

TM2D3

6

Q9BRN9
LCLAIIPLTISISRI

TMC7

611

Q7Z402
FGILLTCRLLIARKP

TMEM35A

121

Q53FP2